Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Top Cited Papers
Open Access
- 7 May 2015
- journal article
- research article
- Published by Elsevier BV in Cell Reports
- Vol. 11 (7), 1018-1030
- https://doi.org/10.1016/j.celrep.2015.04.031
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- The Innate Immune DNA Sensor cGAS Produces a Noncanonical Cyclic Dinucleotide that Activates Human STINGCell Reports, 2013
- STING is a direct innate immune sensor of cyclic di-GMPNature, 2011
- Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cellsThe Journal of Experimental Medicine, 2011
- Type I interferon is selectively required by dendritic cells for immune rejection of tumorsThe Journal of Experimental Medicine, 2011
- Identification and characterization of a loss-of-function human MPYS variantGenes & Immunity, 2011
- c-di-AMP Secreted by Intracellular Listeria monocytogenes Activates a Host Type I Interferon ResponseScience, 2010
- One-Flask Syntheses of c-di-GMP and the [Rp,Rp] and [Rp,Sp] Thiophosphate AnaloguesOrganic Letters, 2010
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunityNature, 2009
- A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMPThe Journal of Experimental Medicine, 2009
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signallingNature, 2008